To compete in the highly lucrative market, Novo Nordisk announced in March that it was also cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through ...

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.